FOR INFORMATION CONTACT:
Lori Gardner, Senior Director
Communications & Marketing
301.984.9496 ext. 226
For Immediate Release: March 1, 2011
Cancer Care Leaders to Gather for Association of Community Cancer Centers' 37th Annual National Meeting
ROCKVILLE, Md.—Leaders from the nation’s hospital-based cancer programs and oncology practices will gather in Washington, D.C., for the Association of Community Cancer Centers’ (ACCC) 37th Annual National Meeting. Join us as the nation’s oncology experts discuss forecasted trends and challenges and the effects of healthcare reform on oncology care.
WHEN: Friday, March 25, 2011 – Saturday, March 26, 2011
WHERE: Washington Hilton, Washington, D.C.
In this tumultuous year of new regulations, declining reimbursements, new partnerships, and shifts in sites of care, this is the one national oncology meeting that interprets the changes and complexities that face community oncology.
The full agenda is available at www.accc-cancer.org. Here are meeting highlights that you won’t want to miss:
Healthcare Reform and Regulatory Changes
Healthcare Reform from the Congressional Perspective
Friday, March 25, 8:10 am – 9:20 am
Will the 112th Congress change the face and future of healthcare reform? Hear what newly elected legislators have to say.
CMS and Its Role in Changing Payment Models
Friday, March 25, 1:00 pm – 1:45 pm
Learn directly from CMS leaders as they discuss new payment models and their effects on the oncology community.
HHS, Healthcare Reform, and Cancer Care
Friday, March 25, 1:45 pm – 2:30 pm
The healthcare reform law mandates new responsibilities for the Department of Health and Human Services (HHS). Richard Popper, Deputy Director for Insurance Programs, Center for Consumer Information and Insurance Oversight, will examine agency plans and programs that may affect cancer care.
Future Trends in Cancer Care
Friday, March 25, 2011, 10:40 am – 12:00 pm
Saturday, March 26, 8:45 am – 9:30 am
Take a peek into 2021: What will cancer care look like and how will legislative, economic, and clinical drivers force cancer programs to re-examine how they deliver care?
HITECH & Meaningful Use
Saturday, March 26, 11:15 am – 12:00 pm
With meaningful use objectives, physicians will be required to give patients electronic access to their health information and provide information and tools to help engage patients and their families in their care. How do meaningful use criteria relate to the goal of engaging patients and their families to improve care coordination? Which HITECH (Health Information Technology for Economic and Clinical Health Act) tools work best? What do patients want from their providers? Find the answers.
The Oncology IT Balancing Act: Integration and Functionality
Saturday, March 26, 1:30 pm – 2:30 pm
This presentation will cover the experiences and feedback directly from healthcare providers using Oncology IT systems. The vendors fully rated and measured in this study are Elekta, IntrinsiQ, and Varian. Others vendors measured are BMSi, Epic, and US Oncology. The presentation will share an insight into strengths, weaknesses and observations from both clinical and IT end users.
Guidelines vs. Physician Autonomy vs. Personalized Medicine with Predictive Assays
Friday, March 25, 3:00 pm – 4:00 pm
A panel of oncologists will discuss the emerging dilemma in cancer treatment planning: the role of physician autonomy. Should physicians select therapies based on their preferences from their own experience and interpretations of data, meetings, discussions, and published papers? Is it better to comply with published evidence-based guidelines and pathways developed by NCCN, ASCO, ASH, and/or US Oncology? And where do emerging tools for personalized medicine fit in, the microarrays, biomarkers, and assays that can predict drug sensitivity of individual patients?
Economics of Pathways
Friday, March 25, 4:00 pm – 5:00 pm
A clinical pathway is a management tool for standardizing the way physicians and other healthcare providers treat a disease, based on nationally recognized and accepted clinical guidelines and/or other commonly used clinical parameters. Learn about business models designed to provide and document the most effective care for patients using evidence-based clinical pathways, and how a collaborative approach between payers and providers to implement a standard, evidence-based oncology clinical pathways program can increase quality and cost effectiveness of cancer care.
Cancer Data Analysis
Saturday, March 26, 2:30 pm – 3:30 pm
Oncology service lines are complex entities comprised of many different accounting units. This presentation will describe how cancer programs can access and analyze all oncology-related hospital data in order to strategize and evaluate disease-specific centers of excellence. The oncology business unit of the Virginia Commonwealth University Health System has created and used such a data analysis approach over the past 12 years, to meet the ever-increasing demand for data intelligence.
Structuring Research Programs to Increase Utilization of Services
Saturday, March 26, 3:30 pm – 4:30 pm
The biopharmaceutical industry has experienced a revolution in research and development (R&D) fueled by the advent of high throughput screening, bioinformatics, genomics, and combinatorial chemistry. The resulting landscape provides opportunity for community cancer centers to structure clinical trial programs focused on innovative collaborations with community oncologists and other ancillary service providers. These relationships can form the foundation of a sustainable physician strategy to positively impact patient outcomes and provide revenue to offset declining reimbursement.